The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hemostatic Forceps Market Research Report 2024

Global Hemostatic Forceps Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1409237

No of Pages : 111

Synopsis
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
The global Hemostatic Forceps market was valued at US$ 60 million in 2023 and is anticipated to reach US$ 81 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Forceps, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Forceps.
Report Scope
The Hemostatic Forceps market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Forceps market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Forceps manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medline
B. Braun
CareFusion
Asa Dental
Sklar
Scanlan International
Shanghai Medical Instruments
Lawton
Hu-Friedy
Xinhua Surgical
Towne Brothers
Teleflex Medical
Delacroix Chevalier
YDM
M A Corporation
MedGyn Products
Inami
Ted Pella
Medicon eG
J & J Instruments
American Diagnostic
Segment by Type
Halstead Mosquito Hemostatic Forceps
Kelly and Crile Hemostatic Forceps
Rochester-Carmalt Hemostatic Forceps
Segment by Application
Surgical
Dissection
Dental
Laparoscopic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Forceps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Hemostatic Forceps Market Overview
1.1 Product Overview and Scope of Hemostatic Forceps
1.2 Hemostatic Forceps Segment by Type
1.2.1 Global Hemostatic Forceps Market Value Comparison by Type (2024-2030)
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Hemostatic Forceps Segment by Application
1.3.1 Global Hemostatic Forceps Market Value by Application: (2024-2030)
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Global Hemostatic Forceps Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Forceps Revenue 2019-2030
1.4.2 Global Hemostatic Forceps Sales 2019-2030
1.4.3 Global Hemostatic Forceps Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostatic Forceps Market Competition by Manufacturers
2.1 Global Hemostatic Forceps Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostatic Forceps Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostatic Forceps Average Price by Manufacturers (2019-2024)
2.4 Global Hemostatic Forceps Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Forceps, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Forceps, Product Type & Application
2.7 Hemostatic Forceps Market Competitive Situation and Trends
2.7.1 Hemostatic Forceps Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic Forceps Players Market Share by Revenue
2.7.3 Global Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic Forceps Retrospective Market Scenario by Region
3.1 Global Hemostatic Forceps Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostatic Forceps Global Hemostatic Forceps Sales by Region: 2019-2030
3.2.1 Global Hemostatic Forceps Sales by Region: 2019-2024
3.2.2 Global Hemostatic Forceps Sales by Region: 2025-2030
3.3 Global Hemostatic Forceps Global Hemostatic Forceps Revenue by Region: 2019-2030
3.3.1 Global Hemostatic Forceps Revenue by Region: 2019-2024
3.3.2 Global Hemostatic Forceps Revenue by Region: 2025-2030
3.4 North America Hemostatic Forceps Market Facts & Figures by Country
3.4.1 North America Hemostatic Forceps Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostatic Forceps Sales by Country (2019-2030)
3.4.3 North America Hemostatic Forceps Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Forceps Market Facts & Figures by Country
3.5.1 Europe Hemostatic Forceps Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostatic Forceps Sales by Country (2019-2030)
3.5.3 Europe Hemostatic Forceps Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Forceps Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic Forceps Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostatic Forceps Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostatic Forceps Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Forceps Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Forceps Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostatic Forceps Sales by Country (2019-2030)
3.7.3 Latin America Hemostatic Forceps Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Forceps Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Forceps Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostatic Forceps Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostatic Forceps Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Forceps Sales by Type (2019-2030)
4.1.1 Global Hemostatic Forceps Sales by Type (2019-2024)
4.1.2 Global Hemostatic Forceps Sales by Type (2025-2030)
4.1.3 Global Hemostatic Forceps Sales Market Share by Type (2019-2030)
4.2 Global Hemostatic Forceps Revenue by Type (2019-2030)
4.2.1 Global Hemostatic Forceps Revenue by Type (2019-2024)
4.2.2 Global Hemostatic Forceps Revenue by Type (2025-2030)
4.2.3 Global Hemostatic Forceps Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic Forceps Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostatic Forceps Sales by Application (2019-2030)
5.1.1 Global Hemostatic Forceps Sales by Application (2019-2024)
5.1.2 Global Hemostatic Forceps Sales by Application (2025-2030)
5.1.3 Global Hemostatic Forceps Sales Market Share by Application (2019-2030)
5.2 Global Hemostatic Forceps Revenue by Application (2019-2030)
5.2.1 Global Hemostatic Forceps Revenue by Application (2019-2024)
5.2.2 Global Hemostatic Forceps Revenue by Application (2025-2030)
5.2.3 Global Hemostatic Forceps Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic Forceps Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Corporation Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medline Hemostatic Forceps Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Corporation Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Hemostatic Forceps Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 CareFusion
6.3.1 CareFusion Corporation Information
6.3.2 CareFusion Description and Business Overview
6.3.3 CareFusion Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CareFusion Hemostatic Forceps Product Portfolio
6.3.5 CareFusion Recent Developments/Updates
6.4 Asa Dental
6.4.1 Asa Dental Corporation Information
6.4.2 Asa Dental Description and Business Overview
6.4.3 Asa Dental Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Asa Dental Hemostatic Forceps Product Portfolio
6.4.5 Asa Dental Recent Developments/Updates
6.5 Sklar
6.5.1 Sklar Corporation Information
6.5.2 Sklar Description and Business Overview
6.5.3 Sklar Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sklar Hemostatic Forceps Product Portfolio
6.5.5 Sklar Recent Developments/Updates
6.6 Scanlan International
6.6.1 Scanlan International Corporation Information
6.6.2 Scanlan International Description and Business Overview
6.6.3 Scanlan International Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Scanlan International Hemostatic Forceps Product Portfolio
6.6.5 Scanlan International Recent Developments/Updates
6.7 Shanghai Medical Instruments
6.6.1 Shanghai Medical Instruments Corporation Information
6.6.2 Shanghai Medical Instruments Description and Business Overview
6.6.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
6.7.5 Shanghai Medical Instruments Recent Developments/Updates
6.8 Lawton
6.8.1 Lawton Corporation Information
6.8.2 Lawton Description and Business Overview
6.8.3 Lawton Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lawton Hemostatic Forceps Product Portfolio
6.8.5 Lawton Recent Developments/Updates
6.9 Hu-Friedy
6.9.1 Hu-Friedy Corporation Information
6.9.2 Hu-Friedy Description and Business Overview
6.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
6.9.5 Hu-Friedy Recent Developments/Updates
6.10 Xinhua Surgical
6.10.1 Xinhua Surgical Corporation Information
6.10.2 Xinhua Surgical Description and Business Overview
6.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
6.10.5 Xinhua Surgical Recent Developments/Updates
6.11 Towne Brothers
6.11.1 Towne Brothers Corporation Information
6.11.2 Towne Brothers Hemostatic Forceps Description and Business Overview
6.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
6.11.5 Towne Brothers Recent Developments/Updates
6.12 Teleflex Medical
6.12.1 Teleflex Medical Corporation Information
6.12.2 Teleflex Medical Hemostatic Forceps Description and Business Overview
6.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
6.12.5 Teleflex Medical Recent Developments/Updates
6.13 Delacroix Chevalier
6.13.1 Delacroix Chevalier Corporation Information
6.13.2 Delacroix Chevalier Hemostatic Forceps Description and Business Overview
6.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
6.13.5 Delacroix Chevalier Recent Developments/Updates
6.14 YDM
6.14.1 YDM Corporation Information
6.14.2 YDM Hemostatic Forceps Description and Business Overview
6.14.3 YDM Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.14.4 YDM Hemostatic Forceps Product Portfolio
6.14.5 YDM Recent Developments/Updates
6.15 M A Corporation
6.15.1 M A Corporation Corporation Information
6.15.2 M A Corporation Hemostatic Forceps Description and Business Overview
6.15.3 M A Corporation Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.15.4 M A Corporation Hemostatic Forceps Product Portfolio
6.15.5 M A Corporation Recent Developments/Updates
6.16 MedGyn Products
6.16.1 MedGyn Products Corporation Information
6.16.2 MedGyn Products Hemostatic Forceps Description and Business Overview
6.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
6.16.5 MedGyn Products Recent Developments/Updates
6.17 Inami
6.17.1 Inami Corporation Information
6.17.2 Inami Hemostatic Forceps Description and Business Overview
6.17.3 Inami Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Inami Hemostatic Forceps Product Portfolio
6.17.5 Inami Recent Developments/Updates
6.18 Ted Pella
6.18.1 Ted Pella Corporation Information
6.18.2 Ted Pella Hemostatic Forceps Description and Business Overview
6.18.3 Ted Pella Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Ted Pella Hemostatic Forceps Product Portfolio
6.18.5 Ted Pella Recent Developments/Updates
6.19 Medicon eG
6.19.1 Medicon eG Corporation Information
6.19.2 Medicon eG Hemostatic Forceps Description and Business Overview
6.19.3 Medicon eG Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Medicon eG Hemostatic Forceps Product Portfolio
6.19.5 Medicon eG Recent Developments/Updates
6.20 J & J Instruments
6.20.1 J & J Instruments Corporation Information
6.20.2 J & J Instruments Hemostatic Forceps Description and Business Overview
6.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
6.20.5 J & J Instruments Recent Developments/Updates
6.21 American Diagnostic
6.21.1 American Diagnostic Corporation Information
6.21.2 American Diagnostic Hemostatic Forceps Description and Business Overview
6.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue and Gross Margin (2019-2024)
6.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
6.21.5 American Diagnostic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Forceps Industry Chain Analysis
7.2 Hemostatic Forceps Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Forceps Production Mode & Process
7.4 Hemostatic Forceps Sales and Marketing
7.4.1 Hemostatic Forceps Sales Channels
7.4.2 Hemostatic Forceps Distributors
7.5 Hemostatic Forceps Customers
8 Hemostatic Forceps Market Dynamics
8.1 Hemostatic Forceps Industry Trends
8.2 Hemostatic Forceps Market Drivers
8.3 Hemostatic Forceps Market Challenges
8.4 Hemostatic Forceps Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’